While Insulet Corporation has underperformed by -1.72%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PODD rose by 21.81%, with highs and lows ranging from $353.50 to $225.37, whereas the simple moving average jumped by 10.02% in the last 200 days.
On September 08, 2025, Oppenheimer started tracking Insulet Corporation (NASDAQ: PODD) recommending Outperform. A report published by Truist on June 16, 2025, Initiated its previous ‘Buy’ rating for PODD. Goldman also rated PODD shares as ‘Buy’, setting a target price of $380 on the company’s shares in an initiating report dated May 30, 2025. Wolfe Research April 29, 2025d its ‘Outperform’ rating to ‘Peer Perform’ for PODD, as published in its report on April 29, 2025. RBC Capital Mkts’s report from March 06, 2025 suggests a price prediction of $340 for PODD shares, giving the stock a ‘Outperform’ rating. Bernstein also rated the stock as ‘Outperform’.
Analysis of Insulet Corporation (PODD)
Further, the quarter-over-quarter increase in sales is 32.88%, showing a positive trend in the upcoming months.
One of the most important indicators of Insulet Corporation’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 19.18% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.79, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and PODD is recording 638.58K average volume. On a monthly basis, the volatility of the stock is set at 2.97%, whereas on a weekly basis, it is put at 2.72%, with a loss of -3.88% over the past seven days. Furthermore, long-term investors anticipate a median target price of $364.36, showing growth from the present price of $318.0, which can serve as yet another indication of whether PODD is worth investing in or should be passed over.
How Do You Analyze Insulet Corporation Shares?
The Medical Devices market is dominated by Insulet Corporation (PODD) based in the USA. When comparing Insulet Corporation shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 96.78, there is a growth in quarterly earnings of -87.70%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.42%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 101.15% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
